Oral prednisolone supplement abolishes the acute adverse effects following initiation of depot bromocriptine therapy

Clinical Endocrinology

Volumn 45, Issue 4, 1996, Pages 447-451

  Jenkins, Paul J ^a   Jain, Ajay ^a   Jones, Sharon L ^a   Besser, G M ^a   Grossman, A B ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; BROMOCRIPTINE MESILATE; HYDROCORTISONE; INSULIN; PLACEBO; PREDNISOLONE; PROLACTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERPROLACTINEMIA; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029824977     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.8240834.x     Document Type: Article

References (18)

1. Allan, S.G., Cornbleet, M.A., Warrington, P.S., Golland, I.M., Leonard, R.C.F. & Smyth, J.F. (1984) Dexamethasone and high dose mctoclopramide: efficacy in controlling cisplatin-induced nausea and vomiting. British Medical Journal, 289, 878-879.
2. Bouloux, P.M.G., Moult, P.J.A., Besser, G.M. & Grossman, A. (1987) Clinical evaluation of lisuride in the management of hyperprolactinaemia. British Medical Journal, 294, 1323-1324.
3. Ciccarelli, E., Miola, C., Avataneo, T., Camanni, F., Grossman, A. & Besser, G.M. (1989) Long term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinaemia. Fertility and Sterility, 52, 930-935.
4. Ciccarelli, E., Touzel, R., Besser, G.M. & Grossman, A. (1987) Terguride, a new dopamine-agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptine. Fertility and Sterility, 49, 589-594.
5. Franks, S., Horrocks, P.M., Lynch, S.S., Butt, W.R. & London, D.R. (1981) Treatment of hyperprolactinaemia with pergolide mesylate: acute effects and preliminary evaluation of long-term treatment. Lancet, 2, 659-661.
6. Grossman, A., Bouloux, P.G., Loneragan, R., Recs, L.H., Wass, J.A.H. & Besser, G.M. (1985) A comparison of the clinical activity of mesulergine and pergolide in the treatment of hyperprolactinaemia. Clinical Endocrinology, 22, 611-616.
7. Grossman, A., Ross, R., Wass, J.A.H. & Besser, G.M. (1986) Depot-bromocriptine treatment for prolactinomas and acromegaly. Clinical Endocrinology, 24, 231-238.
8. Grossman, A., Wass, J.A.H. & Besser, G.M. (1987) The rapid diagnosis of sensitivity or resistance to dopamine agonists with depot bromocriptine. Acta Endocrinologica, 116, 275-281.
9. Homburg, R., West, C., Brownell, J. & Jacobs, H.S. (1990) A double-blind study comparing a new, non-ergot, long-acting dopamine agonist, CV 205-502, with bromocriptine in women with hyperprolactinaemia. Clinical Endocrinology, 32, 565-571.
10. Mallei, A.M., Ferrair, C., Barolid, P., Cavioni, V., Paracchi, A., Calparoli, C., Romano, C., Spellechia, D., Gerevini, G. & Crosignani, P.C. (1988) Prolactin lowering effect of acute and once weekly repetitive oral administration of cabergoline at two dose levels in hyperprolactinaemic patients. Journal of Clinical Endocrinology and Metabolism, 66, 193-198.
11. Siegal, S. & Castellan Jr, N.J. (1988) Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill Book Company, New York.
12. Smith, D.B., Newlands, E.S., Rustin, G.J.S., Begent, R.H.J., Howells, N., McQuade, B. & Bagshawe, K.D. (1991) Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet, 338, 487-490.
13. Talyor, R. (1996) Successful management of hyperemesis gravidarum using steroid therapy. Quarterly Journal of Medicine, 99, 103-107.
14. The Italian Group for Antiemetic Research (1995) Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. New England Journal of Medicine, 332, 1-5.
15. Thorner, M.O., McNeilly, A.S., Hagen, C. & Besser, G.M. (1974) Long-term treatment of gelactorrhoea and hypogonadism with bromocriptine. British Medical Journal, 2, 419-422.
16. Trainer, P.J. & Besser, G.M. (1995) Insulin tolerance test (ITT). In The Bart's Endocrine Protocols. Pp. 4-6. Churchill Livingstone, London.
17. Verhelst, J.A., Froud, A.L., Touzel, R., Wass, J.A.H., Besser, G.M. & Grossman, A. ( 1991) Acute and long-term effects of once-daily bromocriptine and a new non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinaemia: a double blind study. Acta Endocrinologica, 125, 385-391.
18. Webster, J., Piscitelli, G., Polli, A., Ferrari, C., Ismail, I. & Scanlon, M.F. (1994) A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinaemic amenorrhoea. New England Journal of Medicine, 331, 904-909.